Product Information
MECLIZINE 25 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0757 per EA under NDC 59651080801. Its NADAC has been published 122 times since Jun 5, 2024.
FDA first approved this application on Sep 17, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651080801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202640FDA Approved
9/17/2012
TE Code
AA
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 25 MG TABLET has been published 122 times since Jun 5, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0757 per EA |
|---|---|
| All-time high | $0.0916 (Jul 10, 2024) |
| All-time low | $0.0705 (Nov 20, 2024) |
| 52-week high | $0.0843 |
| 52-week low | $0.0757 |
| Median price | $0.0814 |
| Average price | $0.0821 |
| Largest weekly change | +22.5% (Aug 21, 2024) |
| Weeks tracked | 122 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MECLIZINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 25 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0757 per EA (NDC 59651080801), effective Sep 30, 2026.
How has the price of MECLIZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 25 MG TABLET has held within roughly two percent of its current level. It has been tracked across 122 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for MECLIZINE 25 MG TABLET?
Since Jun 5, 2024, the NADAC for MECLIZINE 25 MG TABLET has ranged from a low of $0.0705 (Nov 20, 2024) to a high of $0.0916 (Jul 10, 2024), with a median of $0.0814 per EA.
Are there cheaper alternatives to MECLIZINE 25 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MECLIZINE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MECLIZINE 25 MG TABLET?
MECLIZINE 25 MG TABLET (NDC 59651080801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.